These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2168763)

  • 1. Is decreased imipramine binding by platelet membranes in major depression associated with plasma autoantibodies to imipramine binding sites?
    Alosachie I; Peter JB; Tsuchihashi H; Knight DL; Nemeroff CB
    Biol Psychiatry; 1990 Aug; 28(4):365-8. PubMed ID: 2168763
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.
    Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET
    Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma of depressed patients enhances platelet imipramine binding.
    Marazziti D; Rotondo A; Perugi G; Placidi GF; Cassano GB; Pacifici GM
    Biol Psychiatry; 1989 Apr; 25(7):985-7. PubMed ID: 2541806
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet tritiated imipramine binding in patients suffering from mania.
    Ellis PM; Mellsop GW; Beeston R; Cooke RR
    J Affect Disord; 1991 Jul; 22(3):105-10. PubMed ID: 1655851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine binding in depressed patients with psychogenic pain.
    Mellerup ET; Dam H; Kim MY; Loldrup D; Plenge P; Rosenberg R; Schepelern S
    Psychiatry Res; 1990 Apr; 32(1):29-34. PubMed ID: 2161548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding sites in depressed patients and healthy controls: a comparison between morning and afternoon samples.
    Gentsch C; Lichsteiner M; Gastpar M; Gastpar G; Feer H
    J Affect Disord; 1989; 16(1):65-70. PubMed ID: 2536764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet [3H]-imipramine binding is not modified in Alzheimer's disease.
    Galzin AM; Davous P; Roudier M; Lamour Y; Poirier MF; Langer SZ
    Psychiatry Res; 1989 Jun; 28(3):289-94. PubMed ID: 2548223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine binding in depression and other psychiatric conditions.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand Suppl; 1988; 345():61-8. PubMed ID: 2852451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet 3H-imipramine binding in psychogenic pain patients.
    Mellerup ET; Bech P; Hansen HJ; Langemark M; Loldrup D; Plenge P
    Psychiatry Res; 1988 Nov; 26(2):149-56. PubMed ID: 2853399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased platelet 3H-imipramine binding in Parkinson's disease.
    Schneider LS; Chui HC; Severson JA; Sloane RB
    Biol Psychiatry; 1988 Jul; 24(3):348-51. PubMed ID: 2840980
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression.
    Husain MM; Knight DL; Doraiswamy PM; Figiel GS; McDonald WM; Boyko OB; Krishnan KR; Nemeroff CB
    Biol Psychiatry; 1991 Apr; 29(7):665-70. PubMed ID: 1647227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression.
    Slotkin TA; Whitmore WL; Barnes GA; Krishnan KR; Blazer DG; Knight DL; Nemeroff CB
    Biol Psychiatry; 1989 Mar; 25(6):687-91. PubMed ID: 2538161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine binding in depressive patients diagnosed according to different criteria.
    Plenge P; Mellerup ET; Gjerris A
    Acta Psychiatr Scand; 1988 Aug; 78(2):156-61. PubMed ID: 2851919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoceptor and imipramine receptor binding during the menstrual cycle.
    Stowell LI; McIntosh CJ; Cooke R; Ellis PM
    Acta Psychiatr Scand; 1988 Sep; 78(3):366-8. PubMed ID: 2848395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.
    Maj M; Mastronardi P; Cerreta A; Romano M; Mazzarella B; Kemali D
    Biol Psychiatry; 1988 Aug; 24(4):469-72. PubMed ID: 2841987
    [No Abstract]   [Full Text] [Related]  

  • 20. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
    Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R
    Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.